Key Proteo Announces Acceptance of First Manuscript Publication to the International Journal for Neonatal Screening

Key Proteo, Inc. is proud to announce the acceptance of their manuscript, titled Advancing Newborn Screening in Washington State: A Novel Multiplexed LC-MS/MS Proteomic Assay for Wilson Disease and Inborn Errors of Immunity, for publication in the International Journal for Neonatal Screening. This manuscript details a pilot study involving over 30,000 samples from Washington State, marking a significant milestone for Key Proteo, Inc. We extend our gratitude to the Washington State Newborn Screening Laboratory, Alberta Precision Laboratories, and Seattle Children's Research Institute for their invaluable support.

While the official release is expected in approximately one month, we are eager to provide insights into this significant milestone. We appreciate your patience and continued support. For further updates, please check back regularly or subscribe to our newsletter.